CN102836299A - 治疗强直性脊柱炎的益肾消痹丸 - Google Patents
治疗强直性脊柱炎的益肾消痹丸 Download PDFInfo
- Publication number
- CN102836299A CN102836299A CN2012103668114A CN201210366811A CN102836299A CN 102836299 A CN102836299 A CN 102836299A CN 2012103668114 A CN2012103668114 A CN 2012103668114A CN 201210366811 A CN201210366811 A CN 201210366811A CN 102836299 A CN102836299 A CN 102836299A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- kidney tonifying
- disappears
- preparatas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 72
- 206010002556 Ankylosing Spondylitis Diseases 0.000 title claims abstract description 49
- 239000006187 pill Substances 0.000 title claims abstract description 8
- 208000002193 Pain Diseases 0.000 title abstract description 39
- 230000036407 pain Effects 0.000 title abstract description 37
- 241000005787 Cistanche Species 0.000 claims abstract description 33
- 241000736246 Pyrola Species 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims description 66
- 231100000862 numbness Toxicity 0.000 claims description 52
- 229940079593 drug Drugs 0.000 claims description 47
- 241000522620 Scorpio Species 0.000 claims description 34
- 241001489978 Eupolyphaga Species 0.000 claims description 33
- 241000756943 Codonopsis Species 0.000 claims description 32
- 241000131808 Scolopendra Species 0.000 claims description 31
- 241000255791 Bombyx Species 0.000 claims description 30
- 241000237636 Pheretima Species 0.000 claims description 28
- 210000000582 semen Anatomy 0.000 claims description 22
- 241000903946 Clematidis Species 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000241550 Cyathula Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 239000003610 charcoal Substances 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 238000005498 polishing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 51
- 208000006820 Arthralgia Diseases 0.000 abstract description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 208000026435 phlegm Diseases 0.000 abstract description 12
- 208000024891 symptom Diseases 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 4
- 208000011580 syndromic disease Diseases 0.000 abstract description 4
- 241000255789 Bombyx mori Species 0.000 abstract description 3
- 241000258920 Chilopoda Species 0.000 abstract description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 241000239226 Scorpiones Species 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 241000270273 Ptyas dhumnades Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 206010061363 Skeletal injury Diseases 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 44
- 210000004369 blood Anatomy 0.000 description 41
- 210000000952 spleen Anatomy 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 20
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 239000009490 scorpio Substances 0.000 description 17
- 206010010904 Convulsion Diseases 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 230000036461 convulsion Effects 0.000 description 13
- 210000001624 hip Anatomy 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 12
- 230000005714 functional activity Effects 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 244000025254 Cannabis sativa Species 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 230000002146 bilateral effect Effects 0.000 description 8
- 239000003172 expectorant agent Substances 0.000 description 8
- 230000003419 expectorant effect Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000036592 analgesia Effects 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 206010043376 Tetanus Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 201000007227 lymph node tuberculosis Diseases 0.000 description 6
- 241000218158 Clematis Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010019468 Hemiplegia Diseases 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000007096 poisonous effect Effects 0.000 description 5
- 206010039073 rheumatoid arthritis Diseases 0.000 description 5
- 210000003131 sacroiliac joint Anatomy 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000004394 hip joint Anatomy 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000009527 percussion Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 244000145591 rattan cane Species 0.000 description 4
- 235000012950 rattan cane Nutrition 0.000 description 4
- -1 retinoid Chemical compound 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 241000227129 Aconitum Species 0.000 description 3
- 241000233788 Arecaceae Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000361919 Metaphire sieboldi Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000010100 anticoagulation Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000000527 greater trochanter Anatomy 0.000 description 3
- 208000012285 hip pain Diseases 0.000 description 3
- 230000000147 hypnotic effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000004705 lumbosacral region Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 241001233061 earthworms Species 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- USDOQCCMRDNVAH-KKUMJFAQSA-N β-cadinene Chemical compound C1C=C(C)C[C@H]2[C@H](C(C)C)CC=C(C)[C@@H]21 USDOQCCMRDNVAH-KKUMJFAQSA-N 0.000 description 2
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241001523383 Achnatherum Species 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 241000722953 Akebia Species 0.000 description 1
- 241001506940 Alpinia japonica Species 0.000 description 1
- JLUQTCXCAFSSLD-NXEZZACHSA-N Anemonin Chemical compound C1=CC(=O)O[C@]11[C@@]2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-NXEZZACHSA-N 0.000 description 1
- JLUQTCXCAFSSLD-UHFFFAOYSA-N Anemonin Natural products C1=CC(=O)OC11C2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-UHFFFAOYSA-N 0.000 description 1
- 208000008822 Ankylosis Diseases 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283026 Cervus elaphus Species 0.000 description 1
- 108010023798 Charybdotoxin Proteins 0.000 description 1
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001327638 Cimex lectularius Species 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000007875 Femur Head Necrosis Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241001251068 Formica fusca Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 241001312741 Gekko swinhonis Species 0.000 description 1
- 241001113926 Gelsemium Species 0.000 description 1
- 241001391115 Gelsemium elegans Species 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101000777488 Heteractis magnifica DELTA-stichotoxin-Hmg2b Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000510612 Imperatoria Species 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 241001098499 Lanceolata Species 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001532077 Manfreda virginica Species 0.000 description 1
- 244000217433 Melampodium divaricatum Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241001669656 Odontobutis obscura Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000206469 Pulsatilla Species 0.000 description 1
- 241000736243 Pyrola rotundifolia Species 0.000 description 1
- LQVPXEJSWXVRLA-UHFFFAOYSA-N Renifolin Natural products CC1=CCc2c(O)cc(C)c(OC3OC(CO)C(O)C(O)C3O)c2C1 LQVPXEJSWXVRLA-UHFFFAOYSA-N 0.000 description 1
- 208000010476 Respiratory Paralysis Diseases 0.000 description 1
- 206010039361 Sacroiliitis Diseases 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000271897 Viperidae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- QMAYBMKBYCGXDH-UHFFFAOYSA-N alpha-amorphene Natural products C1CC(C)=CC2C(C(C)C)CC=C(C)C21 QMAYBMKBYCGXDH-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003160 antidiuretic agent Substances 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000020028 corn beer Nutrition 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- CNVQLPPZGABUCM-LIGYZCPXSA-N ctx toxin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]3CSSC[C@@H](C(N[C@@H](CC=4C5=CC=CC=C5NC=4)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC3=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CO)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3NC=NC=3)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N2)C(C)C)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC1=O)=O)CCSC)C(C)C)[C@@H](C)O)NC(=O)[C@H]1NC(=O)CC1)C1=CC=CC=C1 CNVQLPPZGABUCM-LIGYZCPXSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 150000004816 dichlorobenzenes Chemical class 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229930002995 diterpene alkaloid Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- XCDQFROEGGNAER-PFOIMGGJSA-N epi-Friedelanol Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CC[C@H](O)[C@@H]1C XCDQFROEGGNAER-PFOIMGGJSA-N 0.000 description 1
- FWTBRZMBHIYQSW-UHFFFAOYSA-N epifriedelanol Natural products CC1C(O)C(O)CC2C1(C)CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)C(O)CC34C FWTBRZMBHIYQSW-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002192 fatty aldehydes Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- SQMGCPHFHQGPIF-UUKFDUHUSA-N gns9eex31x Chemical compound O[C@@H]([C@]([C@H]([C@H](O)[C@]12O)OC)(O)C3)[C@H]2[C@@H]3[C@@]2([C@H](C[C@H]3O)OC)[C@H]4[C@@H]1[C@H](OC)[C@@H]2[C@]3(COC)CN4CC SQMGCPHFHQGPIF-UUKFDUHUSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 229930195247 licorice glycoside Natural products 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- USDOQCCMRDNVAH-UHFFFAOYSA-N sigma-cadinene Natural products C1C=C(C)CC2C(C(C)C)CC=C(C)C21 USDOQCCMRDNVAH-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗强直性脊柱炎的益肾消痹丸,属于中药骨伤病治疗技术领域,由熟地黄、肉苁蓉、当归、土鳖虫、全蝎、鹿衔草、乌梢蛇、蜈蚣、蜂房、地龙、炙甘草、桂枝、炒僵蚕、党参、制天南星、制川乌、制草乌。本发明益肾消痹丸价格便宜,标、本同治,且对强直性脊柱炎等痰瘀型痹证有特效,有效的缩短了病人的治疗时间,减轻了病人的痛苦,具有良好的经济效益。
Description
技术领域
本发明涉及中药骨伤病治疗技术领域,尤其是一种治疗强直性脊柱炎的益肾消痹丸。
背景技术
日常生活中,骨病是一种常见病、多发病,骨病包括风湿性关节炎、类风湿性关节炎、退行性关节炎、强直性脊柱炎、颈椎病、腰椎病、肩周炎、骨质增生、股骨头坏死、产后风、骨质疏松症、腰椎间盘突出症等等。其中强直性脊柱炎是脊柱的慢性进行性炎症,侵及骶髂关节、关节突附近韧带和近躯干的大关节,导致纤维性或骨性强直和畸形,其患者多为中青年人群,平均发病年龄低至25岁,给无数患者带来身体痛苦和经济负担。
现有的治疗方法:
1、口服药物:非甾体抗炎药、柳氮磺吡啶、甲氨蝶呤、糖皮质激素、生物制剂等;
2、外科治疗:人工全髋关节置换术、脊柱椎体截骨纠正畸形。
现有的治疗方法中药物价格昂贵,容易引起不良反应,手术后风险大,价格昂贵,病人痛苦,愈合缓慢,更甚致残,会形成治标不治本之弊。
目前,关于治疗强直性脊柱炎的中药也有相关的专利文献报导,例如:公开号为CN102018792A、名称为“一种治疗强直性脊柱炎的中药”的发明专利,该专利公开的中药是以狗脊、鹿角霜、淫羊藿、灵仙、牛膝、没药、土元和勾藤为原料药,按照合理的比例混合制成;公开号为CN101129720A、名称为“一种治疗强直性脊柱炎的复方药物”的发明专利,该专利公开的中药是以金银花、淫羊藿、土茯苓、黄柏、补骨脂、赤芍、苍术、续断、肉苁蓉、川牛膝、秦艽和铁丝威灵仙为原料药,按照合理的比例混合制成各种口服制剂或外用制剂;公开号为CN102406704A、名称为“治疗强直性脊柱炎的中药制剂”的发明专利,该专利公开的中药是以独活、鸡血藤、桑寄生、三七、丹参、泽兰、乌梢蛇和徐长卿为原料药,按照合理的比例混合制成各种口服制剂或外用制剂,具有补益肝肾、强筋、养肾的功效,治疗强直性脊柱炎见效快、疗效高、攻不伤正、补不留邪,有经络通、气血畅、疼痛止的特点。
发明内容
本发明解决的技术问题是:针对目前治疗强直性脊柱炎的现有状况,提供了一种价格便宜,标、本同治,且对痰瘀型痹证有特效的治疗强直性脊柱炎的益肾消痹丸。
本发明采用技术方案是:
本发明提供了一种治疗强直性脊柱炎的益肾消痹丸,以重量份表示,所述益肾消痹丸由以下原料药组成:熟地黄75~95份、肉苁蓉30~45份、当归55~65份、土鳖虫25~42份、全蝎30~45份、鹿衔草25~43份、乌梢蛇30~45份、蜈蚣5~15份、蜂房30~45份、地龙30~45份、炙甘草30~50份、桂枝35~45份、炒僵蚕30~45份、党参30~50份、制天南星35~45份、制川乌25~42份、制草乌25~42份。
根据上述的治疗强直性脊柱炎的益肾消痹丸,所述益肾消痹丸由以下原料药组成:熟地黄75~85份、肉苁蓉30~38份、当归55~60份、土鳖虫25~35份、全蝎30~38份、鹿衔草25~35份、乌梢蛇30~38份、蜈蚣5~10份、蜂房30~38份、地龙30~38份、炙甘草30~40份、桂枝35~40份、炒僵蚕30~38份、党参30~40份、制天南星35~40份、制川乌25~35份、制草乌25~35份。
根据上述的治疗强直性脊柱炎的益肾消痹丸,所述益肾消痹丸由以下原料药组成:熟地黄85~95份、肉苁蓉38~45份、当归60~65份、土鳖虫35~42份、全蝎38~45份、鹿衔草35~43份、乌梢蛇38~45份、蜈蚣10~15份、蜂房38~45份、地龙38~45份、炙甘草40~50份、桂枝40~45份、炒僵蚕40~45份、党参40~50份、制天南星40~45份、制川乌35~42份、制草乌35~42份。
本发明还提供了一种治疗强直性脊柱炎的益肾消痹丸,以重量份表示,所述益肾消痹丸由以下原料药组成:熟地黄75~95份、肉苁蓉30~45份、当归55~65份、土鳖虫25~42份、全蝎30~45份、鹿衔草25~43份、乌梢蛇30~45份、蜈蚣5~15份、蜂房30~45份、地龙30~45份、炙甘草30~50份、桂枝35~45份、炒僵蚕30~45份、党参30~50份、制天南星35~45份、制川乌25~42份、制草乌25~42份、鸡血藤75~85份、威灵仙35~50份、川牛膝35~45份、炒白术35~50份、薏苡仁30~50份。
根据上述的治疗强直性脊柱炎的益肾消痹丸,所述益肾消痹丸由以下原料药组成:熟地黄75~85份、肉苁蓉30~38份、当归55~60份、土鳖虫25~35份、全蝎30~38份、鹿衔草25~35份、乌梢蛇30~38份、蜈蚣5~10份、蜂房30~38份、地龙30~38份、炙甘草30~40份、桂枝35~40份、炒僵蚕30~38份、党参30~40份、制天南星35~40份、制川乌25~35份、制草乌25~35份、鸡血藤75~80份、威灵仙35~42份、川牛膝35~40份、炒白术35~42份、薏苡仁30~40份。
根据上述的治疗强直性脊柱炎的益肾消痹丸,所述益肾消痹丸由以下原料药组成:熟地黄85~95份、肉苁蓉38~45份、当归60~65份、土鳖虫35~42份、全蝎38~45份、鹿衔草35~43份、乌梢蛇38~45份、蜈蚣10~15份、蜂房38~45份、地龙38~45份、炙甘草40~50份、桂枝40~45份、炒僵蚕40~45份、党参40~50份、制天南星40~45份、制川乌35~42份、制草乌35~42份、鸡血藤80~85份、威灵仙42~50份、川牛膝40~45份、炒白术42~50份、薏苡仁40~50份。
所述益肾消痹丸制备方法为:首先按照上述治疗强直性脊柱炎的益肾消痹丸的配比比例称取各种原料药,将称取的各种原料药分别粉碎,过100目筛,将粉碎后的各种原料药药粉混合均匀,得到混合细粉,然后每1000g混合细粉分别加入20g淀粉、微晶纤维素1.8g混匀,再加炼蜜100~200g与适量水按照常规方法制丸,最后依次进行干燥、包炭衣、滑石粉打光,即得。
本发明各种原料药的药理作用:
熟地黄,异名:熟地;性味:甘,温;归经:入肝、肾经;功效:补血滋润;益精填髓;主治:血虚萎黄,眩晕心悸,月经不调,崩不止,肝肾阴亏,潮热盗汗,遗精阳痿,不育不孕,月经不调,崩漏下血,腰膝酸软,耳鸣耳聋,头目昏花,须发早白,消渴,便秘,肾虚喘促;熟地黄主要含有环烯醚萜、单萜、氨基酸、糖类及磷酸等多种成分,具有凝血、强心、利尿、降血糖及抑菌等作用。
肉苁蓉,异名:大芸、寸芸、苁蓉、查干告亚;性味:甘、咸,温;归经:入肾、大肠经;功效:补肾阳,益精血,润肠通便;主治:阳痿遗精,腰膝冷痛,筋骨无力,肠燥便秘;肉苁蓉主要含有微量生物碱及结晶性中性物质,具有降血压及使呼吸麻痹等作用。
当归,异名:干归;性味:甘、辛,温;归经:入肝、心、脾经;功效:补血调结,活血止痛,润肠通便;主治:月经不调,闭经痛经,虚塞性腹痛,跌打损伤,痈疽疮疡,血虚性肠燥便秘;当归主要含有烃类、蔗糖维生素B12、维生素A类等物质,具有调整子宫功能状态、抗菌、抗VitE缺乏症、降血压、镇静、镇痛及利尿等作用。
土鳖虫,异名:土鳖、簸箕虫、地鳖虫、地蜱虫、山账螂、地乌龟、土元、臭虫母、盖子虫、土虫、节节虫、蚂蚁虎;性味:咸,寒,有毒;归经:入心、肝、脾经;功效:破血逐瘀,续筋接骨,消肿止痛,下乳通经;主治:癌瘕积聚、血滞经闭、产后瘀血腹痛、跌打损伤、木舌、重舌;土鳖虫主要含有氨基酸、脂肪醛、芳香醛,还含有二氯苯和二甲基二硫醚等其它中药少见的成分,具有抗凝血及调脂等作用。
全蝎,异名:钳蝎、全虫、蝎子;性味:辛,平,有毒;归经:入肝经;功效:息风镇痉,攻毒散结,通络止痛;主治:小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬;全蝎主要含有毒性蛋白、非毒性蛋白及功能性多肽,如蝎毒素Ⅲ、透明质酸酶等,其水解液中含有17种人体必需氨基酸,以及29种无机元素,具有抗癫痫、抗惊厥、镇痛及抗肿瘤等作用。
鹿衔草,异名:鹿蹄草、小秦王草、破血丹、纸背金牛草、大肺筋草、红肺筋草、鹿寿茶、鹿安茶;性味:甘、苦,温;归经:入肺、胃、肝、肾经;功效:补虚、益肾、祛风除湿、活血调经、补肾强骨、止咳、止血;主治:虚腰痛、风湿痹痛、筋骨痿软、新久咳嗽、吐血、衄血、崩漏、外伤出血;鹿衔草全草主要含有熊果酚甙、鞣质、肾叶鹿蹄草甙、挥发油、蔗糖、蔗糖酶、苦杏仁酶等,具有抗心律不齐、抗菌、抗孕及免疫促进等作用。
乌梢蛇,异名:乌蛇、乌花蛇、剑脊蛇、黑风蛇、黄风蛇、剑脊乌梢蛇、南蛇;性味:甘,平;归经:入肝经;功效:祛风,通络,止痉;主治:风湿顽痹,麻木拘挛,中风口眼歪斜,半身不遂,抽搐痉挛,破伤风,麻风疥癣,瘰疬恶疮;乌梢蛇主要含有蛋白质和脂肪,具有镇静、镇痛及灭活蛇毒等作用。
蜈蚣,异名:百足虫、千足虫、金头蜈蚣、百脚;性味:辛,温,有毒;归经:入肝经;功效:息风镇痉,攻毒散结,通络止痛;主治:小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,疮疡,瘰疬,毒蛇咬伤;蜈蚣主要含有组胺样物质、溶血性蛋白质、脂肪油、胆固醇、蚁酸及多种氨基酸等,具有止痉、抗真菌及抗肿瘤等作用。
蜂房,异名:露蜂房、马蜂窝、蜂巢、野蜂窝、黄蜂窝、百穿之巢;性味:甘,平;归经:入胃经;功效:祛风,攻毒,杀虫,止痛,抗过敏;主治:龋齿牙痛,疮疡肿毒,乳痈,瘰疬,皮肤顽癣,鹅掌风,过敏性体质;蜂房主要含有挥发油、蜂蜡、树脂、蛋白质、铁、钙等,具有抑制炎症、镇痛、促凝血、驱虫、抗血压、扩张血管、强心、抗癌、抗菌及降温作用。
地龙,异名:蚯蚓、丘螾、蜿蟺、地龙子、土蟺、虫蟮;性味:咸,寒;归经:入肝、脾、膀胱经;功效:清热熄风,平喘,通络,利尿;主治:壮热惊风,手足抽搐,肺热喘咳,关节痹痛,半身不遂,热结尿闭;地龙主要含有蚯蚓素、蚯蚓解热碱、嘌呤碱、氨基酸、多种微量元素等,具有溶栓、抗凝、抗心律失常、降血压作用、抗惊厥、镇静、治疗中风、抗癌及平喘等作用。
甘草,异名:美草、密干、蕗草、甜根子、灵通、粉草、棒草;性味:甘,平;归经:入脾、肺、心、胃经;功效:补脾益气,消热解毒,祛痰止咳,缓急止痛;主治:脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹,四肢挛急疼痛,痈肿疮毒;甘草主要含有甘草酸、甘草甙等,具有保护溃疡、解毒、止咳平喘、调节机体免疫及抗心律失常等作用。
桂枝,异名:牡桂;性味:辛、甘,温;归经:入膀胱、心、肺经;功效:解肌发汗,温通血脉,温阳化气,温经除痹,温通胸阳,温中散寒,通经消瘀,平冲降逆;主治:风寒表虚,太阳表郁,表寒里热,血虚受寒,寒滞胞宫,血痹,温化痰饮,温阳利水,太阳蓄水,痰湿瘀血,胸痹,心悸,手足不温,瘀血久积;桂枝主要含有桂皮醛、苯甲酸苄酯、乙酸肉桂酯、β-荜澄茄烯、菖莆烯、香豆精等,具有镇静、镇痛、抗惊厥、解热、抗菌、抗病毒、利尿及消炎等作用。
鸡血藤,异名:血风藤、马鹿藤、紫梗藤、猪血藤、九层风、红藤、活血藤、大血藤、血龙藤、过岗龙、五层血;性味:苦、微甘,温;归经:入肝经;功效:活血补血,舒筋活络;主治:月经不调,血虚闭经,风湿痹痛,中风不遂;鸡血藤主要含有表无羁萜醇、胡萝卜甙、β-谷甾醇、7-酮基-β-谷甾醇、木豆异黄酮等,具有补血、使血细胞增加、血红蛋白升高、抑制心脏、降低血压及抗癌等作用。
威灵仙,异名:能消、葳灵仙、葳苓仙、铁脚威灵仙、灵仙、黑脚威灵仙、九草阶、风车、铁杆威灵仙、鲜须草、黑骨头、黑木通、铁搧帚、七寸风、铁脚灵仙、牛闲草、牛杆草、老虎须、辣椒藤、灵仙藤、黑灵仙、黑须公、芝查藤根;性味:辛、咸,温,有毒;归经:入膀胱经;功效:清热利湿,通经络,消痰,散癖积;主治:痛风,顽痹,腰膝冷痛,脚气,疟疾,癌瘕积聚,破伤风,扁桃体炎,诸骨鲠咽;威灵仙主要含有白头翁素、白头翁内酯、甾醇、三萜、糖类、皂甙、内酯、酚类、氨基酸、有机酸等,具有降血压、抑制心脏、降血糖、抗利尿及抗真菌等作用。
川牛膝,异名:牛膝,天全牛膝,都牛胶,米心牛膝,大牛膝;性味:甘、微苦,平;归经:入肝、肾经;功效:活血通经,祛风除湿,利尿通淋;主治:血瘀闭经,痛经,难产,胞衣不下,产后瘀血腹痛,跌打损伤,风湿腰膝疼痛,热淋、血淋;川牛膝主要含有甾醇类、甾酮类等,具有弛缓子宫肌及收缩子宫等作用。
白术,异名:山蓟、杨抱蓟、术、山芥、天蓟、山姜、乞力伽、山精、山连、冬白术;性味:苦、甘,温;归经:入脾、胃经;功效:健脾益气、燥湿利水、止汗、安胎。主治:脾虚食少、腹胀泄泻、痰饮眩悸、水肿、自汗、胎动不安;白术主要含有挥发油、倍半萜内酯化合物、多炔类化合物等,具有利尿、降血糖、强壮、抗凝血、抗肿瘤、抗菌、促造血及促蛋白质合成的作用。
薏苡仁,异名:薏仁、苡米、苡仁、土玉米、薏米、起实、薏珠子、草珠珠、回回米、米仁、六谷子;性味:甘、淡,微寒;归经:入脾、胃、肺经;功效:利水渗湿,健脾止泻,祛湿除痹,清热排脓。主治:水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻;薏苡仁主要包含氨基酸、薏苡素、薏苡酯、三萜化合物、蛋白质、脂肪、碳水化合物、维生素 B1等,具有镇静、镇痛、解热、扩张肺血管及抑制肠管运动等作用。
僵蚕,异名:天虫、姜蚕、白僵蚕;性味:辛、咸,平;归经:入肝、肺、胃经;功效:祛风定惊,化痰散结;主治:惊风抽搐,咽喉肿痛,颌下淋巴结炎,面部麻痹,皮肤瘙痒;僵蚕主要含有蛋白质、脂肪、草酸铵、氨基酸以及铁、锌、铜、锰、铬等微量元素,具有抗惊厥、抗癌及催眠等作用。
党参,异名:上党人参、防风党参、黄参、防党参、上党参、狮头参、中灵草、黄党;性味:甘、微酸,平;归经:入脾、肺经;功效:补中益气,健脾益肺;用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴;主治:脾肺气虚证,气血两虚证,气津两伤证;党参主要含有甾醇类、生物碱及含氮成分、三萜类及挥发性成分等,具有抗胃黏膜损伤、增强机体免疫力、增强造血功能、抗应激、镇静、催眠及抗惊厥等作用。
天南星,异名:南星、白南星、山苞米、蛇包谷、山棒子;性味:苦、辛,温;归经:入肺、肝、脾经;功效:燥湿化痰,祛风定惊,消肿散结;主治:洽中风痰壅,口眼喎斜,半身不遂,癫癎,惊风,破伤风,风痰眩晕,喉痹,瘰疬,痈肿,跌扑折伤,蛇虫咬伤:天南星主要含有三萜皂甙、D-甘露醇、安息香酸、淀粉等,具有镇静、催眠、抗肿瘤及祛痰等作用。
川乌,异名:鹅儿花、铁花、五毒;性味:辛、苦,热,大毒;归经:入心、肝、肾、脾经;功效:祛风除湿,温经止痛;主治:风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛;川乌主要含有双酯类二萜生物碱、单酯型二萜类生物碱等,具有抗炎、镇痛、降血糖、强心、麻醉及抗癌等作用。
草乌,异名:鸭头、药羊蒿、鸡头草、百步草、堇、芨、乌头、乌喙、奚毒、鸡毒、茛、千秋、毒公、果负、耿子、帝秋、独白草、土附子、竹节乌头、金鸦、断肠草;性味:辛,热,有毒;归经:入肝、脾、肺经;功效:搜风胜湿,散寒止痛,开痰,消肿;主治:风寒湿痹,中风瘫痪,破伤风,头风,脘腹冷痛,痰癖,气块,冷痢,喉痹,痈疽,疔疮,瘰疬;草乌主要包括乌头碱及其水解后生成的乌头原碱、肌醇和鞣质等,具有止痛、麻醉及降压等作用。
药物配伍原理:
素体虚弱,禀赋不足,肝肾精血亏虚,风寒湿深侵肾督,郁久化热,深入骨骱,脊柱。肝肾精血不足,使筋挛骨弱,而邪留不去,渐致痰浊,瘀血阻于体内,而见疾病缠绵难愈,治宜补益肝肾,化痰祛瘀通络,方中熟地补肾填髓,生精养血,肉苁蓉补肾阳,益精血,全当归补血活血,三药合用,共为君药,土元破血逐瘀,续筋接骨,全虫善行走散,走经脉而通络止痛,鹿衔草补肝肾,祛风湿,乌梢蛇祛风通络,透利关节,蜈蚣、全虫通络止痛,蜂房祛风止痛,地龙通经活络,诸药共用为臣,共奏除痹通络之功,《素问·逆调论》说:“营气虚则不仁,卫气虚则不用,营卫俱虚则不仁且不用”,桂枝调和营卫,通经络,助阳气通达四肢,鸡血藤行气补血,舒筋活络而祛风邪。威灵仙通行十二经脉,炙姜蚕祛风除僵结,制南星,川乌、草乌祛寒助阳,以散风寒止痹痛。炒白术补气健脾,燥湿利水,薏苡仁健脾除湿,舒筋缓急,党参补中益气,生津益血,三花相配,顾护胃气,制约大剂祛风湿药峻烈之性,诸药相配,共为佐药。川牛膝与祛风湿之剂相配,调补肝肾,除痹通络,攻补兼施,标本同治,切中病机,使风、寒、湿邪、痰浊、瘀血俱除,精血充足,肝肾强健,痹痛得以缓解。
本发明益肾消痹丸的有益效果是:
(1) 本发明益肾消痹丸在临床中辨证施治,按病因化解,运用到强直性脊柱炎,疗效突出,治愈率高,一般服药10天后,病人临床症状减轻,疼痛缓解,有效的缩短了病人的治疗时间,减轻了病人的痛苦;
(2) 本发明益肾消痹丸还有效的解决了大部分因痰瘀引起的痹证,一方一病,按因下药,在痰瘀型痹证的治疗效果上得到了更进一步提高,完善了痰瘀型痹证的治疗方案,为类风湿性关节炎、顽固性风湿性关节炎等病人群体解决了痛苦;
(3) 本发明益肾消痹丸价格便宜,病人易接受,体现了中医治疗骨病的优势所在,具有良好的经济效益。
本发明益肾消痹丸的适应症:强直性脊柱炎、风湿性关节炎、顽固性风湿性关节炎。
强直性脊柱炎的诊断标准:(1)下腰痛持续至少3个月,疼痛活动后可改善,休息后不减轻;(2)腰椎在前后、侧屈方向的活动受限;(3)胸廓活动度较同年龄、性别的正常人减少。具备单侧Ⅲ~Ⅳ级或双侧Ⅱ~Ⅲ级影像学骶髂关节炎,加上临床标准3条中至少1条。腰骶疼痛,脊背疼痛,腰背活动受限,晨僵,发热,四肢关节红肿热痛,目赤肿痛。口渴或口干不欲饮,肢体困重,大便干,溲黄。舌红,苔黄或黄厚、腻,脉滑数。
本发明益肾消痹丸服用方法:一日3次,一次9g,温开水送服。
疗程: 30天为一个疗程。
表1本发明益肾消痹丸治疗强直性脊柱炎临床资料(总数500人)
诊疗标准:根据中国医药科技局2002年发布的《中药新药临床研究指导原则》,临床治愈:中医临床症状、体征消失或基本消失,症候积分减少≥95%;显效:中医临床症状、体征明显改善,症候积分减少≥70%;有效:中医临床症状、体征均有好转,症候积分减少≥30%;无效:中医临床症状、体征无明显改善,甚或加重,症候积分减少不足30%。
典型病例:
1、崔某,男,42岁,发病15年,晨僵,跛行,颈腰背僵硬,左髋部酸痛,腰膝酸软,功能活动受限,颌柄距6cm,胸阔活动度2cm,指地距17cm,胸腰棘突压痛,左侧大转子叩击痛,手足心热,舌红,苔少,脉细数,查X片示:符合强直性脊柱炎的表现。服用本发明治疗强直性脊柱炎的益肾消痹丸,组方为熟地黄84份、肉苁蓉42份、当归63份、土鳖虫42份、全蝎42份、鹿衔草42份、乌梢蛇42份、蜈蚣15份、蜂房42份、地龙42份、炙甘草42份、桂枝42份、炒僵蚕42份、党参42份、制天南星42份、制川乌42份、制草乌42份、鸡血藤84份、威灵仙42份、川牛膝42份、炒白术42份、薏苡仁42份,以上原料药和蜂蜜3份,服用方法:一日3次,一次9g,温开水送服。30天为一个疗程。服用本发明中成药治疗3个疗程后酸痛减轻,功能活动及中医体征有所改善。继续服用本发明中成药3个疗程后症状基本消失,酸痛缓解,功能活动显著改善,现已参加日常工作。
2、 张某,男,16岁,发病4年,晨僵,腰膝酸软,双髋部僵硬疼痛,功能活动局部受限,颈项稍强,胸阔活动度3cm,颌柄距1cm,双侧大转子叩击痛。舌红,苔少,脉细数。查X片示:双侧骶髂关节间隙模糊,双髋关节间隙变窄,腰椎生理曲度变直,腰椎小关节间隙变模糊。诊断为“强直性脊柱炎”。服用本发明治疗强直性脊柱炎的益肾消痹丸,组方为熟地黄75份、肉苁蓉30份、当归55份、土鳖虫25份、全蝎30份、鹿衔草25份、乌梢蛇30份、蜈蚣5份、蜂房30份、地龙30份、炙甘草30份、桂枝35份、炒僵蚕30份、党参30份、制天南星35份、制川乌25份、制草乌25份,以上原料药和蜂蜜3份,服用方法:一日3次,一次9g,温开水送服。30天为一个疗程。服用本发明中成药治疗2个疗程后双髋疼痛减轻,功能活动及中医体征有所改善。继续服用本发明中成药2个疗程后症状明显改善,酸痛缓解,僵直减轻,功能活动可,现已正常参加学习。
3、任某,男,18岁,发病1年,晨僵,双髋膝交替疼痛,腰椎活动明显受限,腰背肌紧张,颌柄距1cm,指地距15cm,胸阔活动度4cm,手足心热,烦渴,舌红,苔少偏黄,脉细数。查X片示:双侧骶髂关节线模糊,双侧髋关节间隙变窄,腰椎小关节间隙模糊。诊断为“强直性脊柱炎”。服用本发明治疗强直性脊柱炎的益肾消痹丸,组方为熟地黄72份、肉苁蓉30份、当归58份、土鳖虫32份、全蝎32份、鹿衔草36份、乌梢蛇32份、蜈蚣12份、蜂房38份、地龙36份、炙甘草38份、桂枝36份、炒僵蚕36份、党参42份、制天南星36份、制川乌28份、制草乌28份,以上原料药和蜂蜜3份,服用方法:一日3次,一次9g,温开水送服。30天为一个疗程。服用本发明中成药治疗1个疗程后双髋疼痛减轻,功能活动及中医体征有所改善。继续服用本发明中成药1个疗程后症状明显改善,酸痛缓解,僵直减轻,功能活动可,现已正常参加学习。
4、何某,男,19岁,发病3年半,晨僵,双髋膝疼痛,偶有腰部酸痛感,双侧大转子叩击痛,托马斯征阳性,颌柄距3cm,胸阔活动度3.5cm,指地距32cm,骶髂关节叩击痛,口干,五心烦热,舌质红,苔薄少津,脉细数。查X片示:骶髂关节模糊,腰椎生理弯曲变直,腰椎小关节变模糊。诊断为“强直性脊柱炎”。服用本发明治疗强直性脊柱炎的益肾消痹丸,组方为熟地黄80份、肉苁蓉34份、当归58份、土鳖虫30份、全蝎34份、鹿衔草30份、乌梢蛇34份、蜈蚣8份、蜂房34份、地龙34份、炙甘草35份、桂枝38份、炒僵蚕34份、党参35份、制天南星38份、制川乌30份、制草乌30份,以上原料药和蜂蜜3份,服用方法:一日3次,一次9g,温开水送服。30天为一个疗程。服用本发明中成药治疗2个疗程后双髋疼痛减轻,功能活动及中医体征有所改善。继续服用本发明中成药2个疗程后症状明显改善,酸痛缓解,僵直减轻,功能活动可,现已正常参加学习。
5、李某,男,35岁,发病8年,双侧髋膝疼痛,腰部酸软疼痛,伴晨僵,胸阔活动度2cm,指地距27cm,双髋关节内外旋均受限,时潮热盗汗,无心烦热,口渴,舌质红,苔薄黄,脉细数,查X片示 :双侧髋关节间隙变窄,腰椎各小关节模糊不清。诊断为“强直性脊柱炎”。服用本发明治疗强直性脊柱炎的益肾消痹丸,组方为熟地黄84份、肉苁蓉42份、当归63份、土鳖虫42份、全蝎42份、鹿衔草42份、乌梢蛇42份、蜈蚣15份、蜂房42份、地龙42份、炙甘草42份、桂枝42份、炒僵蚕42份、党参42份、天南星(制)42份、制川乌42份、制草乌42份、鸡血藤84份、威灵仙42份、川牛膝42份、炒白术42份、薏苡仁42份,以上原料药和蜂蜜3份,服用方法:一日3次,一次9g,温开水送服。30天为一个疗程。服用本发明中成药治疗3个疗程后酸痛减轻,功能活动及中医体征有所改善。继续服用本发明中成药2个疗程后症状基本消失,酸痛缓解,功能活动显著改善,现已参加日常工作。
具体实施方式
以下结合实施例进一步说明本发明,但并不限制本发明的内容。
实施例1
一种治疗强直性脊柱炎的益肾消痹丸,由以下原料药组成:熟地黄75g、肉苁蓉30g、当归55g、土鳖虫25g、全蝎30g、鹿衔草25g、乌梢蛇30g、蜈蚣5g、蜂房30g、地龙30g、炙甘草30g、桂枝35g、炒僵蚕30g、党参30g、制天南星35g、制川乌25g、制草乌25g;
将以上配比的各原料药分别粉碎、过100目筛,将粉碎后的各种原料药药粉混合均匀,得到混合细粉,然后每1000g混合细粉分别加入20g淀粉、微晶纤维素1.8g混匀,再加炼蜜100~200g与适量水按照常规方法制丸,最后依次进行干燥、包炭衣、滑石粉打光,即得。
实施例2
一种治疗强直性脊柱炎的益肾消痹丸,由以下原料药组成:熟地黄84g、肉苁蓉42g、当归63g、土鳖虫42g、全蝎42g、鹿衔草42g、乌梢蛇42g、蜈蚣15g、蜂房42g、地龙42g、炙甘草42g、桂枝42g、炒僵蚕42g、党参42g、制天南星42g、制川乌42g、制草乌42g;
制备方法与实施例1相同。
实施例3
一种治疗强直性脊柱炎的益肾消痹丸,由以下原料药组成:熟地黄95g、肉苁蓉45g、当归65g、土鳖虫42g、全蝎45g、鹿衔草43g、乌梢蛇45g、蜈蚣15g、蜂房45g、地龙45g、炙甘草50g、桂枝45g、炒僵蚕45g、党参50g、制天南星45g、制川乌42g、制草乌42g;
制备方法与实施例1相同。
实施例4
熟地黄80 g、肉苁蓉34 g、当归58 g、土鳖虫30 g、全蝎34 g、鹿衔草30 g、乌梢蛇34 g、蜈蚣8 g、蜂房34 g、地龙34 g、炙甘草35 g、桂枝38 g、炒僵蚕34 g、党参35 g、制天南星38 g、制川乌30 g、制草乌30 g;
制备方法与实施例1相同。
实施例5
熟地黄90 g、肉苁蓉42 g、当归63 g、土鳖虫38 g、全蝎42 g、鹿衔草39 g、乌梢蛇42 g、蜈蚣12 g、蜂房42 g、地龙42 g、炙甘草45 g、桂枝42 g、炒僵蚕42 g、党参45 g、制天南星42 g、制川乌38 g、制草乌38 g;
制备方法与实施例1相同。
实施例6
一种治疗强直性脊柱炎的益肾消痹丸,由以下原料药组成:熟地黄75g、肉苁蓉30g、当归55g、土鳖虫25g、全蝎30g、鹿衔草25g、乌梢蛇30g、蜈蚣5g、蜂房30g、地龙30g、炙甘草30g、桂枝35g、炒僵蚕30g、党参30g、制天南星35g、制川乌25g、制草乌25g;
制备方法与实施例1相同。
实施例7
一种治疗强直性脊柱炎的益肾消痹丸,由以下原料药组成:熟地黄84g、肉苁蓉42g、当归63g、土鳖虫42g、全蝎42g、鹿衔草42g、乌梢蛇42g、蜈蚣15g、蜂房42g、地龙42g、炙甘草42g、桂枝42g、炒僵蚕42g、党参42g、制天南星42g、制川乌42g、制草乌42g、鸡血藤84g、威灵仙42g、川牛膝42g、炒白术42g、薏苡仁42g;
制备方法与实施例1相同。
实施例8
一种治疗强直性脊柱炎的益肾消痹丸,由以下原料药组成:熟地黄95g、肉苁蓉45g、当归65g、土鳖虫42g、全蝎45g、鹿衔草43g、乌梢蛇45g、蜈蚣15g、蜂房45g、地龙45g、炙甘草50g、桂枝45g、炒僵蚕45g、党参50g、制天南星45g、制川乌42g、制草乌42g、鸡血藤85g、威灵仙50g、川牛膝45g、炒白术50g、薏苡仁50g;
制备方法与实施例1相同。
实施例9
熟地黄80 g、肉苁蓉34 g、当归58 g、土鳖虫30 g、全蝎34 g、鹿衔草30 g、乌梢蛇34 g、蜈蚣8 g、蜂房34 g、地龙34 g、炙甘草35 g、桂枝38 g、炒僵蚕34 g、党参35 g、制天南星38 g、制川乌30 g、制草乌30 g、鸡血藤78 g、威灵仙38 g、川牛膝38 g、炒白术38 g、薏苡仁35 g;
制备方法与实施例1相同。
实施例10
熟地黄90 g、肉苁蓉42 g、当归63 g、土鳖虫38 g、全蝎42 g、鹿衔草39 g、乌梢蛇42 g、蜈蚣12 g、蜂房42 g、地龙42 g、炙甘草45 g、桂枝42 g、炒僵蚕42 g、党参45 g、制天南星42 g、制川乌38 g、制草乌38 g、鸡血藤82 g、威灵仙46 g、川牛膝42 g、炒白术46 g、薏苡仁45 g;
制备方法与实施例1相同。
Claims (7)
1.一种治疗强直性脊柱炎的益肾消痹丸,其特征在于,所述益肾消痹丸由以重量份计的下列原料药组成:熟地黄75~95份、肉苁蓉30~45份、当归55~65份、土鳖虫25~42份、全蝎30~45份、鹿衔草25~43份、乌梢蛇30~45份、蜈蚣5~15份、蜂房30~45份、地龙30~45份、炙甘草30~50份、桂枝35~45份、炒僵蚕30~45份、党参30~50份、制天南星35~45份、制川乌25~42份、制草乌25~42份。
2.根据权利要求1所述的治疗强直性脊柱炎的益肾消痹丸,其特征在于,所述益肾消痹丸由以下原料药组成:熟地黄75~85份、肉苁蓉30~38份、当归55~60份、土鳖虫25~35份、全蝎30~38份、鹿衔草25~35份、乌梢蛇30~38份、蜈蚣5~10份、蜂房30~38份、地龙30~38份、炙甘草30~40份、桂枝35~40份、炒僵蚕30~38份、党参30~40份、制天南星35~40份、制川乌25~35份、制草乌25~35份。
3.根据权利要求1所述的治疗强直性脊柱炎的益肾消痹丸,其特征在于,所述益肾消痹丸由以下原料药组成:熟地黄85~95份、肉苁蓉38~45份、当归60~65份、土鳖虫35~42份、全蝎38~45份、鹿衔草35~43份、乌梢蛇38~45份、蜈蚣10~15份、蜂房38~45份、地龙38~45份、炙甘草40~50份、桂枝40~45份、炒僵蚕40~45份、党参40~50份、制天南星40~45份、制川乌35~42份、制草乌35~42份。
4.一种治疗强直性脊柱炎的益肾消痹丸,其特征在于,所述益肾消痹丸由以重量份计的下列原料药组成:熟地黄75~95份、肉苁蓉30~45份、当归55~65份、土鳖虫25~42份、全蝎30~45份、鹿衔草25~43份、乌梢蛇30~45份、蜈蚣5~15份、蜂房30~45份、地龙30~45份、炙甘草30~50份、桂枝35~45份、炒僵蚕30~45份、党参30~50份、制天南星35~45份、制川乌25~42份、制草乌25~42份、鸡血藤75~85份、威灵仙35~50份、川牛膝35~45份、炒白术35~50份、薏苡仁30~50份。
5.根据权利要求4所述的治疗强直性脊柱炎的益肾消痹丸,其特征在于,所述益肾消痹丸由以下原料药组成:熟地黄75~85份、肉苁蓉30~38份、当归55~60份、土鳖虫25~35份、全蝎30~38份、鹿衔草25~35份、乌梢蛇30~38份、蜈蚣5~10份、蜂房30~38份、地龙30~38份、炙甘草30~40份、桂枝35~40份、炒僵蚕30~38份、党参30~40份、制天南星35~40份、制川乌25~35份、制草乌25~35份、鸡血藤75~80份、威灵仙35~42份、川牛膝35~40份、炒白术35~42份、薏苡仁30~40份。
6.根据权利要求4所述的治疗强直性脊柱炎的益肾消痹丸,其特征在于,所述益肾消痹丸由以下原料药组成:熟地黄85~95份、肉苁蓉38~45份、当归60~65份、土鳖虫35~42份、全蝎38~45份、鹿衔草35~43份、乌梢蛇38~45份、蜈蚣10~15份、蜂房38~45份、地龙38~45份、炙甘草40~50份、桂枝40~45份、炒僵蚕40~45份、党参40~50份、制天南星40~45份、制川乌35~42份、制草乌35~42份、鸡血藤80~85份、威灵仙42~50份、川牛膝40~45份、炒白术42~50份、薏苡仁40~50份。
7.根据权利要求1~6任一项所述的治疗强直性脊柱炎的益肾消痹丸,其特征在于,所述益肾消痹丸制备方法为:首先按照上述治疗强直性脊柱炎的益肾消痹丸的配比比例称取各种原料药,将称取的各种原料药分别粉碎,过100目筛,将粉碎后的各种原料药药粉混合均匀,得到混合细粉,然后每1000g混合细粉分别加入20g淀粉、微晶纤维素1.8g混匀,再加炼蜜100~200g与适量水按照常规方法制丸,最后依次进行干燥、包炭衣、滑石粉打光,即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210366811 CN102836299B (zh) | 2012-09-28 | 2012-09-28 | 治疗强直性脊柱炎的益肾消痹丸 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210366811 CN102836299B (zh) | 2012-09-28 | 2012-09-28 | 治疗强直性脊柱炎的益肾消痹丸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102836299A true CN102836299A (zh) | 2012-12-26 |
| CN102836299B CN102836299B (zh) | 2013-12-18 |
Family
ID=47364202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210366811 Active CN102836299B (zh) | 2012-09-28 | 2012-09-28 | 治疗强直性脊柱炎的益肾消痹丸 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102836299B (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104225532A (zh) * | 2014-09-12 | 2014-12-24 | 郑州中医骨伤病医院 | 治疗强直性脊柱炎的健脾温肾丸 |
| CN105168578A (zh) * | 2015-09-28 | 2015-12-23 | 郑州中医骨伤病医院 | 一种治疗强直性脊柱炎的益肾健骨丸中药 |
| CN106038804A (zh) * | 2016-06-29 | 2016-10-26 | 南京中医药大学 | 一种治疗强直性脊柱炎的中药制剂 |
| CN107335025A (zh) * | 2016-09-30 | 2017-11-10 | 河南省中医药研究院 | 一种用于治疗痹症的中药组合物及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1569100A (zh) * | 2003-12-26 | 2005-01-26 | 吴英萍 | 一种治疗类风湿性关节炎、强直性脊柱炎的药物及其制备方法 |
-
2012
- 2012-09-28 CN CN 201210366811 patent/CN102836299B/zh active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1569100A (zh) * | 2003-12-26 | 2005-01-26 | 吴英萍 | 一种治疗类风湿性关节炎、强直性脊柱炎的药物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 张华津: "中医药治疗强直性脊柱炎临床研究进展", 《河北中医》, vol. 32, no. 3, 31 December 2010 (2010-12-31), pages 461 - 463 * |
| 郭玉梅: "中医辨证治疗强直性脊柱炎78例临床观察", 《中国医药指南》, vol. 9, no. 25, 31 December 2011 (2011-12-31), pages 123 - 124 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104225532A (zh) * | 2014-09-12 | 2014-12-24 | 郑州中医骨伤病医院 | 治疗强直性脊柱炎的健脾温肾丸 |
| CN104225532B (zh) * | 2014-09-12 | 2018-03-16 | 郑州中医骨伤病医院 | 治疗强直性脊柱炎的健脾温肾丸 |
| CN105168578A (zh) * | 2015-09-28 | 2015-12-23 | 郑州中医骨伤病医院 | 一种治疗强直性脊柱炎的益肾健骨丸中药 |
| CN106038804A (zh) * | 2016-06-29 | 2016-10-26 | 南京中医药大学 | 一种治疗强直性脊柱炎的中药制剂 |
| CN106038804B (zh) * | 2016-06-29 | 2020-07-24 | 南京中医药大学 | 一种治疗强直性脊柱炎的中药制剂 |
| CN107335025A (zh) * | 2016-09-30 | 2017-11-10 | 河南省中医药研究院 | 一种用于治疗痹症的中药组合物及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102836299B (zh) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104510892A (zh) | 一种治疗甲状腺肿瘤的中药配方 | |
| CN102836299B (zh) | 治疗强直性脊柱炎的益肾消痹丸 | |
| CN103110762A (zh) | 一种治疗骨折久不愈合的中药组合物 | |
| CN104784624A (zh) | 一种治疗消化不良的中药 | |
| CN104383515A (zh) | 一种治疗气血亏虚型产后风湿的中药组合物 | |
| CN105106515A (zh) | 一种用于治疗心绞痛的中药制剂及制备方法 | |
| CN104208311A (zh) | 治疗美尼尔氏综合症的中药丸 | |
| CN102671180B (zh) | 一种治疗风湿腰痛的药物及其制备方法 | |
| CN101357208A (zh) | 一种治疗慢性浅表性胃炎的中药组合物 | |
| CN104758701A (zh) | 一种胃结石碎石后护理治疗的药物及其制备方法 | |
| CN104906502A (zh) | 一种用于治疗鸡伤热的药物组合物及其制备方法 | |
| CN104758668A (zh) | 一种治疗水热蕴结证型臌胀病的中药组合物 | |
| CN105687961A (zh) | 一种治疗冠状动脉粥样硬化冲剂的制备方法 | |
| CN102755467B (zh) | 一种治疗冻伤的罗沙冬油膏及其制备方法 | |
| CN108853252A (zh) | 一种治疗骨质疏松症的中药 | |
| CN104771634A (zh) | 一种治疗寒凝脉痹型骨质疏松的药物与及其制备方法 | |
| CN105031335A (zh) | 一种胃结石微波碎石后护理治疗的药物及其制备方法 | |
| CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
| CN104056217A (zh) | 治疗老年咳喘的中药制剂 | |
| CN104491598A (zh) | 一种治疗带状疱疹的中药组合物 | |
| CN104758849A (zh) | 一种治疗绝经期骨质疏松症的药物组合物及其制备方法 | |
| CN104127620A (zh) | 一种治疗股骨头坏死的中药制剂 | |
| CN104042872A (zh) | 治疗小儿感冒的中药组合物及其制备方法 | |
| CN102451406A (zh) | 一种治疗风湿病的中药 | |
| CN104922444A (zh) | 一种治疗心阳不振型心悸病的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |
